Robin Frye

Phase II Multi-Institutional Trial of the Histone Deacetylase Inhibitor Romidepsin As Monotherapy for Patients With Cutaneous T-Cell Lymphoma

Richard Piekarz, Robin Frye, Maria L. Turner et al. · Journal of Clinical Oncology · 2009 · 737 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Phase 2 trial of romidepsin in patients with peripheral T-cell lymphoma

Richard Piekarz, Robin Frye, H. Miles Prince et al. · Blood · 2011 · 490 citations · Full text

Medicine, Oncology, Pharmacotherapy +9

Randomized, Double-Blind, Placebo-Controlled Phase IIB Trial of the Cyclooxygenase Inhibitor Ketorolac as an Oral Rinse in Oropharyngeal Leukoplakia

James L. Mulshine, Jane C. Atkinson, Robert O. Greer et al. · Clinical Cancer Research · 2004 · 103 citations · Full text

Dentistry, Oral Medicine, Pharmacotherapy +11

Laboratory correlates for a phase II trial of romidepsin in cutaneous and peripheral T‐cell lymphoma

Susan E. Bates, Zhirong Zhan, Kenneth Steadman et al. · British Journal of Haematology · 2009 · 77 citations · Full text

Medicine, Oncology, Pharmacology +15

Population Pharmacokinetics of Romidepsin in Patients with Cutaneous T-Cell Lymphoma and Relapsed Peripheral T-Cell Lymphoma

Sukyung Woo, Erin R. Gardner, Sandra B. Ockers et al. · Clinical Cancer Research · 2009 · 75 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17